<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hedge Fund News From HedgeCo.Net &#187; vertex pharmaceuticals</title>
	<atom:link href="http://www.hedgeco.net/news/tag/vertex-pharmaceuticals/feed" rel="self" type="application/rss+xml" />
	<link>http://www.hedgeco.net/news</link>
	<description>Breaking Hedge Fund News</description>
	<lastBuildDate>Mon, 13 Feb 2012 16:50:25 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.2.1</generator>
		<item>
		<title>Out With Hedge Funds, In With Blue Bloods</title>
		<link>http://www.hedgeco.net/news/02/2009/out-with-hedge-funds-in-with-blue-bloods.html</link>
		<comments>http://www.hedgeco.net/news/02/2009/out-with-hedge-funds-in-with-blue-bloods.html#comments</comments>
		<pubDate>Fri, 20 Feb 2009 00:00:00 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[Syndicated]]></category>
		<category><![CDATA[amp]]></category>
		<category><![CDATA[bets]]></category>
		<category><![CDATA[cambridge ma]]></category>
		<category><![CDATA[chief-financial-officer]]></category>
		<category><![CDATA[experimental drug]]></category>
		<category><![CDATA[good mood]]></category>
		<category><![CDATA[insights]]></category>
		<category><![CDATA[mdash]]></category>
		<category><![CDATA[midst]]></category>
		<category><![CDATA[nasdaq]]></category>
		<category><![CDATA[positive cash flow]]></category>
		<category><![CDATA[recession]]></category>
		<category><![CDATA[robert w baird]]></category>
		<category><![CDATA[secondary stock]]></category>
		<category><![CDATA[thomas russo]]></category>
		<category><![CDATA[vertex pharmaceuticals]]></category>
		<category><![CDATA[volatile stocks]]></category>
		<category><![CDATA[vrtx]]></category>

		<guid isPermaLink="false"></guid>
		<description><![CDATA[Xconomy &#8211; Vertex Pharmaceuticals has been around the block with biotech hedge funds. These are the people who aim to get rich trading volatile stocks second-to-second, and make big bets, long or short, on whether an experimental drug will work. Now that Vertex has passed some of the riskiest stages of drug development, the company [...]]]></description>
		<wfw:commentRss>http://www.hedgeco.net/news/02/2009/out-with-hedge-funds-in-with-blue-bloods.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Performance optimized by W3 Total Cache. Learn more: http://www.w3-edge.com/wordpress-plugins/

Page Caching using disk: enhanced
Database Caching 1/9 queries in 0.310 seconds using disk: basic
Object Caching 199/224 objects using disk: basic

Served from: www.hedgeco.net @ 2012-02-13 18:28:46 -->
